Salgim efficacy in inpatients therapy of bronchial asthma
Abstract
An investigation of clinical efficacy, safety and dispensation in airways of 0.1% salbutamol hemisuccinate nebulized solution was performed in moderate to severe bronchial asthma patients under a 10-day inpatient treatment. The analysis showed the Russian β2-agonist to be an effective medication for bronchial asthma inpatient treatment. It fits to all safety requirements and has the equal efficacy but more beneficial cost-effectiveness compared with the foreign analog Ventolin.
About the Authors
D. B. Uteshev
Клиническая больница М СЧ №1 "АМО ЗиЛ", НИИ пульмонологии Минздрава РФ
Russian Federation
Russian Federation
A. A. Karabinenko
Клиническая больница М СЧ №1 "АМО ЗиЛ", НИИ пульмонологии Минздрава РФ
Russian Federation
Russian Federation
V. I. Svetlakov
Клиническая больница М СЧ №1 "АМО ЗиЛ", НИИ пульмонологии Минздрава РФ
Russian Federation
Russian Federation
A. S. Sokolov
Клиническая больница М СЧ №1 "АМО ЗиЛ", НИИ пульмонологии Минздрава РФ
Russian Federation
Russian Federation
References
1. Чучалин. А.Г., Черняев A.Л., Вуазен К. Патология органов дыхания у ликвидаторов аварии на Чернобыльской АЭС. М.: Грант; 1998. 255-256.
2. Чучалин А.Г. Пульмонология в России и пути ее развития. В кн.: Чучалин А.Г. (ред.) Актуальные проблемы пульмонологии. М.: Универсум Паблишинг; 2000. 15-52.
3. Newman S.P. Characteristics of radiolabelled versus unlableled formulations. J. Aerosol. Med. 1996; 9 (suppl.l): S37-S47.
4. Newman S.P., Pitcfirni G.R., Hirst P.H. et al. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur. Respir. J. 2000; 16: 178-183.
Review
For citations:
Uteshev D.B., Karabinenko A.A., Svetlakov V.I., Sokolov A.S. Salgim efficacy in inpatients therapy of bronchial asthma. PULMONOLOGIYA. 2002;(3):92-95. (In Russ.)
Views:
163
Email this article 